ketotifen has been researched along with Graft vs Host Disease in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
Excerpt | Relevance | Reference |
---|---|---|
"Ketotifen is an anti-H-1 antihistamine with MC-stabilizing properties." | 5.29 | Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts. ( Levi-Schaffer, F; Nagler, A; Segal, V; Slavin, S, 1995) |
"Ketotifen is an anti-H-1 antihistamine with MC-stabilizing properties." | 1.29 | Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts. ( Levi-Schaffer, F; Nagler, A; Segal, V; Slavin, S, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagler, A | 1 |
Segal, V | 1 |
Slavin, S | 1 |
Levi-Schaffer, F | 1 |
1 other study available for ketotifen and Graft vs Host Disease
Article | Year |
---|---|
Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.
Topics: 3T3 Cells; Adolescent; Adult; Animals; Cell Division; Child; Child, Preschool; Chronic Disease; Dino | 1995 |